NCT05758844

Brief Summary

To assess safety and feasebility of the "safe-line" technique in a multicenter international collaboration.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Apr 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Apr 2023Dec 2026

First Submitted

Initial submission to the registry

January 30, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 8, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

April 30, 2023

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

March 8, 2023

Status Verified

March 1, 2023

Enrollment Period

2.6 years

First QC Date

January 30, 2023

Last Update Submit

March 4, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Incidence of adverse events

    collect eventual complications (incidence of: 1- axis thrombosis; 2- microembolization; 3-hematoma)

    7 days

  • Incidence of spinal cord ischemia improvement or resolution

    collect all events that in case of post-operative (48-72hrs) spinal cord ischemia had symptoms mitigation (1-paraplegia improvement; 2 - paraplegia complete resolution)

    30 days

Interventions

Safe-line approach

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Inclusion of all patients treated for thoraco abdominal aortic aneurysm with endovascular repair and use of safe line technique

You may qualify if:

  • Thoraco-abdominal aortic aneurysm including type I,II,III,IV and V.
  • Pararenale aneurysm
  • Thoracoabdominal aortic aneurysm Elective and Urgent, endovascular repair;
  • Endovascular repair of any thoracoabdominal aortic condition

You may not qualify if:

  • thoraco-abdominal aortic aneurysm open repair

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vascular and Endovascular Clinic - Padova University

Padua, 35020, Italy

RECRUITING

MeSH Terms

Conditions

Aortic Aneurysm, Thoracoabdominal

Condition Hierarchy (Ancestors)

Aortic Aneurysm, AbdominalAortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Central Study Contacts

Michele Piazza, Pr.

CONTACT

Francesco Squizzato, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 30, 2023

First Posted

March 8, 2023

Study Start

April 30, 2023

Primary Completion

December 1, 2025

Study Completion (Estimated)

December 1, 2026

Last Updated

March 8, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will share

With other partecipating centers

Locations